Thrivent Financial For Lutherans Sells 2,527 Shares of Express Scripts Holding Company (NASDAQ:ESRX)
Thrivent Financial For Lutherans decreased its position in Express Scripts Holding Company (NASDAQ:ESRX) by 0.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 938,584 shares of the company’s stock after selling 2,527 shares during the period. Thrivent Financial For Lutherans owned approximately 0.16% of Express Scripts Holding worth $59,919,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in ESRX. Burt Wealth Advisors lifted its stake in Express Scripts Holding by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after acquiring an additional 174 shares during the period. CKW Financial Group increased its position in shares of Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after purchasing an additional 300 shares during the last quarter. TrimTabs Asset Management LLC purchased a new stake in shares of Express Scripts Holding during the 1st quarter valued at about $121,000. Capital Analysts LLC increased its position in shares of Express Scripts Holding by 5.6% during the 1st quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock valued at $124,000 after purchasing an additional 100 shares during the last quarter. Finally, IHT Wealth Management LLC increased its position in shares of Express Scripts Holding by 8.1% during the 1st quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after purchasing an additional 145 shares during the last quarter. Institutional investors own 88.69% of the company’s stock.
In other Express Scripts Holding news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now owns 11,500 shares in the company, valued at $735,195. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the sale, the vice president now directly owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Insiders have sold 5,641 shares of company stock valued at $357,317 in the last three months. 0.68% of the stock is currently owned by company insiders.
Several research firms have recently commented on ESRX. Robert W. Baird reaffirmed a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a research report on Friday, September 1st. Morgan Stanley increased their target price on shares of Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a report on Thursday, August 10th. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating for the company. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Raymond James Financial, Inc. reaffirmed an “underperform” rating on shares of Express Scripts Holding in a report on Monday, October 9th. Six analysts have rated the stock with a sell rating, eleven have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts Holding presently has an average rating of “Hold” and a consensus target price of $69.45.
Shares of Express Scripts Holding Company (NASDAQ ESRX) traded down 0.92% on Friday, reaching $57.14. The company’s stock had a trading volume of 3,729,017 shares. The company has a market capitalization of $33.00 billion, a price-to-earnings ratio of 9.92 and a beta of 0.88. The stock has a 50-day moving average price of $61.87 and a 200-day moving average price of $62.44. Express Scripts Holding Company has a 1-year low of $56.82 and a 1-year high of $77.50.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. Express Scripts Holding’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the business posted $1.57 EPS. On average, equities research analysts forecast that Express Scripts Holding Company will post $6.99 EPS for the current year.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.